534 results on '"Cancelliere, A."'
Search Results
2. Aneurysm Neck Overestimation has a Relatively Modest Impact on Simulated Hemodynamics
3. Run analysis of potential evapotranspiration and soil moisture for investigating flash droughts in Sicily
4. Modeling extreme meteorological droughts from paleo-climatic reconstructions using a metastatistical framework
5. Deriving hydro-meteorological thresholds for landslide early warning using multi-layer soil moisture information
6. Challenges for flood hazard and risk assessment in Mozambique: the case of Megaruma and Muaguide rivers
7. Assessing the impacts of future climate change scenarios on water systems supplied by karst aquifers
8. Seyyed Hossein Nasr's Metaphysical Theodicy
9. Hypertriglyceridemia in young adults with a 22q11.2 microdeletion
10. The butterfly effect: improving brain cone-beam CT image artifacts for stroke assessment using a novel dual-axis trajectory
11. Integrating computational fluid dynamics data into medical image visualization workflows via DICOM
12. Bark beetle and woodborer responses to stand thinning and prescribed fire in northeastern <scp>US</scp> coastal and inland pitch pine barrens
13. Cell Model Network-UK from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
14. Supplementary Table 1 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
15. Supplementary Figure 4 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
16. Supplementary Figure 2 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
17. Supplementary Figure 2 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
18. Supplementary Figure 3 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
19. Supplementary Figure 5 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
20. Supplementary Figure 1 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
21. Data from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
22. Supplementary Figure 3 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
23. Supplementary Figures 1 - 4 from BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors
24. Supplementary Table 3 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
25. Supplementary Tables 1 - 3 from BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors
26. Supplementary Figure 4 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
27. Supplementary Figure 1 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
28. Supplementary Table 2 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
29. Supplementary Table 1 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
30. Data from BRAF V600E Is a Determinant of Sensitivity to Proteasome Inhibitors
31. Data from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
32. Supplementary Table S2 from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
33. Data from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
34. Supplementary Data from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
35. Supplementary Table S1 from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
36. Supplementary Figure from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
37. Supplementary Table from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
38. Supplementary Materials and Methods from Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
39. Supplementary Table S3 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
40. Supplementary Legends and Figures from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
41. Supplementary Table S3 from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
42. Data from Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
43. Supplementary Figures and Tables from Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
44. Supplementary Table S2 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
45. Supplementary Table S1 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
46. Data from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
47. Supplementary Table S4 from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
48. Supplementary Figure Legends from Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
49. Data from A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
50. A Rational Approach to Meshing Cerebral Venous Geometries for High-Fidelity Computational Fluid Dynamics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.